1 The involvement of protein kinase C in the presynaptic modulation of stimulated acetylcholine release was investigated in rabbit hippocampus. 2 Slices of the rabbit hippocampus, labelled with [3H]-acetylcholine, were superfused with medium and stimulated electrically during superfusion.
Introduction
The role of inositol triphosphate and diacylglycerol as second messengers has been well established during the last few years (Berridge, 1984; Abdel-Latif, 1986 (Kuo et al., 1983) indicate a possible participation of protein kinase C in 'Author for correspondence. the modulation of neurotransmitter release from noradrenergic and 5-hydroxytryptaminergic (Feuerstein et al., 1987) nerve terminals in the rabbit hippocampus.
In the present study, the possible involvement of protein kinase C in the modulation of the stimulationevoked [3H]-acetylcholine release from rabbit hippocampal slices has been investigated. As cholinergic nerve terminals of the rabbit hippocampus are endowed with muscarine autoreceptors which inhibit the electrically-evoked release of acetylcholine (Strittmatter et al., 1982) , experiments were performed to see whether the effects ofthe phorbol ester were, at least in part, due to an inactivation of the autoinhibitory feedback mechanism.
In addition to the muscarine autoreceptor mechanism, evoked release of acetylcholine from rabbit hippocampus is inhibited by activation of presynaptically located A,-adenosine (Jackisch et al., 1984) and ic-opioid receptors (Jackisch et al., 1986) . Therefore, further work to discover whether these heteroreceptor-coupled mechanisms are affected by phorbol esters was undertaken.
Methods

Superfusion experiments
Superfusion experiments have been performed as reported previously by Strittmatter et al. (1982 The fractional rate of tritium outflow (5 min)-' was calculated as tritium outflow per 5 min/tritium content in the slice at the start of the respective 5 min period (Hertting et al., 1980) . The stimulation-evoked overflow of tritium was calculated by subtraction of the basal outflow from the total outflow of tritium. The basal outflow was assumed to decline linearly from the fraction 5min before to the fraction 15-20 min after the onset of stimulation. The evoked-overflow of tritium (SI, S2) was expressed as a percentage fraction of the tritium content of the slice at the start of the respective stimulation period. As shown by Richardson & Szerb (1974) (Castagna et al., 1982) , increased the evoked tritium overflow in a concentration-dependent manner (Figure 1 Table 2 ). .tio SJS of the the effect of polymyxin B as an inhibitor ofthis enzyme ars) are given. (Kuo et al., 1983) was studied. Polymyxin B was ant at the onset administered from 15 to 40 min before S2 onwards, in 3.41 ± 0.14% concentrations up to 100 pM. Polymyxin B diminished oup: 5-7; sigthe evoked tritium overflow in a time-and concentracontrol (+):
tion-dependent manner (Table 3) . Basal outflow was increased by 100 pM polymyxin B after a superfusion period of 15 min by 13% (b2/b, = 0.74 ± 0.03, n = 4; P < 0.05 vs. control see Table 1 ), and after 40 min of superfusion by 42% (b2/b, = 0.95 ± 0.04, n = 9; After preincubation, the slices were superfused with medium containing hemicholinium-3 (10pM) and stimulated twice electrically (S.; S2). 413-PDB was present from 15 min before S2 onwards in the concentrations indicated. Drug effects on basal outflow are expressed as ratio bJb, between the fractional rate of outflow immediately before S2 (95-100 min) and the fractional rate of outflow immediately before S, (55-60 min). Means ± s.e.mean of n observations are given; significant differences from drug-free control: ***P<0.001; ****P<0.0001. (Figure 2 ).
In the presence of the acetylcholine esterase inhibitor physostigmine, the inhibitory effect of endogenous acetylcholine was strongly augmented. The electrically-evoked overflow of tritium was reduced from about 3% ofthe tissue tritium content at 3- the onset of stimulation, when hemicholinium-3 was present alone, to about 1%, when physostigmine was given in addition. The effects of atropine (2 gM) and 4P-PDB (1 gLM), administered alone or in combination, were tested in the presence of physostigmine. The relative effects of both atropine and 4p-PDB on the evoked overflow of tritium were increased following inhibition of acetylcholine esterase up to 353% in the case of the antagonist and to 129% in the case of the phorbol ester, given alone, respectively. In the presence of physostigmine the effects of the phorbol ester and atropine were again slightly greater than additive. When both drugs were given in combination, the relative increase of the evoked overflow of tritium was to 528%. However, it should be emphasized, that the absolute effect of 4P-PDB (in terms of tissue tritium content), in contrast to that of atropine, was not increased by inhibition of the enzymatic cleavage of endogenous acetylcholine. The electrically-evoked release of acetylcholine from brain slices was diminished by the muscarine receptor agonists carbachol (1 gM) by 35% and by oxotremorine (1 M) by 67% (Table 5 ). Both carbachol and oxotremorine also showed an inhibitory effect on the evoked tritium overflow, when they were added to the medium in combination with 4P-PDB (Table 5 ). Since the overflow of tritium was increased in the presence of the phorbol ester, the relative inhibitory effects of both muscarine receptor agonists were reduced. However, the net effect of inhibition of the tritium overflow by carbachol and oxotremorine did not differ whether in the absence or presence ofthe phorbol ester (Table 5 ). The net effects were obtained by calculating the difference between the control value and the value obtained in the presence of the autoreceptor agonists and the difference between the value obtained for the phorbol ester alone and for the phorbol ester plus the respective agonist.
Adenosine and opioid receptor-mediated release modulation in thepresence of4P-PDB The electrically-evoked tritium overflow from rabbit hippocampal slices is inhibited by activation of A,-adenosine (Jackisch et al., 1984) and c-opioid-receptors (Jackisch et al., 1986) which are located at the cholinergic nerve terminals. The effects of the A,-adenosine receptor agonist (-)-PIA and the preferential x-opioid receptor agonist EKC on the evoked tritium overflow were studied in the presence of 4p-PDB (Tables 6, 7) All drugs were given from 15 min before the second stimulation period onwards. As with the muscarine receptor agonists, the relative inhibitory effects ofboth heteroreceptor agonists were reduced in the presence of the phorbol ester, whereas their net effects (calculated by subtracting the respective S2/SI values) remained unchanged compared to the results obtained in the absence of 4P-PDB (Table 6, 7) . In contrast, the 4P-PDB-induced net enhancement of the evoked tritium overflow was not influenced under these conditions by activation of either the Al-or the ic-opioid-heteroreceptor-coupled mechanisms.
Similar results were obtained when the experiments were performed during muscarine autoreceptor blockade in the presence of atropine (Tables 6, 7 ). Due to endogenous acetylcholine the evoked overflow of tritium was increased in the presence of the muscarine receptor antagonist. Therefore, under these conditions the net effect of inhibition of the evoked overflow by (-)-PIA and EKC was also enhanced. No significant difference between the net inhibitory effects caused by the heteroreceptor agonists in the presence or absence Table 5 Effects ofthe muscarine receptor agonists carbachol and oxotremorine on the evoked tritium overflow in the presence of 4p-phorbol 12, 13-dibutyrate (40-PDB) Drug Hippocampal slices incubated with [3H]-choline were stimulated electrically twice (S.; S2) during superfusion. Hemicholinium-3 (10p&M) was present throughout. Superfusion with medium containing carbachol (1pM) or oxotremorine (1 pM), alone, respectively, or in combination with 4p-PDB was started from 15 min before S2 onwards.
SI ± s.e.mean (in % of tissue tritium at the onset of stimulation) was 2.82 ± 0.08% (n = 34). n number of experiments. Significant inhibitory effects of the muscarine agonists on the evoked tritium overflow 'compared to drug-free control, bcompared to the value obtained in the presence of 4P-PDB: **P<0.01; ****P<0.0001. atropine (2 pM) were added to the superfusion medium from 15 min before S2 onwards. S. ± s.e.mean (in % ofthe tissue tritium content at the onset ofstimulation) was 2.85 ± 0.61 (n = 60). The ratios S2/S, ofthe overflow evoked by the two stimulation periods ofeach group are given. Significance of the inhibitory effect of (-)-PIA in the absence or presence of 4l-PDB: ****P<0O0J0l. n = number of experiments.
of the phorbol ester was seen.
Discussion
The involvement of protein kinase C in the modulation of acetylcholine release in rabbit hippocampus is supported by several findings. First, the protein kinase C activating phorbol ester 4J3-PDB enhanced the electrically-evoked release of acetylcholine in a concentration-dependent manner (Figure 1 ). Second, its inactive 4a-isomer (Ashendal 1985) , was without any effect up to a concentration of 10 gM (Figure 1 ). Third, polymyxin B, described by Kuo et al. (1983) , as a rather selective protein kinase C inhibitor, reduced the stimulation-evoked transmitter release and, in addi- (Tanaka et al., 1986; Versteeg & Florijn, 1987) and synaptosomes (Nichols et al., 1987) has been measured and with electrophysiological studies performed on nerve muscle preparations (Haimann et al., 1987; Murphy & Smith, 1987; Shapira et al., 1987) . During recent years the presence of a presynaptically located protein kinase C in brain slices (Girard et al., 1985) , and the phosphorylation of several membrane proteins, including a 87 kDa substrate, by protein kinase C during depolarization has been demonstrated (Wu et al., 1982) . As reported recently by Nichols et al. (1987) , phosphorylation of the 87 kDa substrate by phorbol ester-activated protein kinase C in synaptosomes was in parallel with the enhancement of stimulated release. In contrast, the inactive 4a-phorbol esters were without effect either on release or phosphorylation. The precise biochemical mechanism underlying the enhancement of release caused by phorbol esters is as yet not clear. The possibility that facilitation ofrelease by 413-PDB is due to a blockade of the high-affinity uptake mechanism for choline can be excluded, since superfusion was performed in the presence of the uptake inhibitor hemicholinium-3. The observation that the active phorbol ester predominantly potentiates Ca2"-dependent and TTX-sensitive stimulationevoked release ( However, these findings are in contrast to an electrophysiological study (Murphy & Smith, 1987) , where the phorbol ester-induced increase ofrelease remained unchanged in Ca2"-deficient solutions and to experiments performed on PC12 cells, where voltagedependent Ca2" channels appeared to be under an inhibitory control (Di Virgilio et al., 1986; Messing et al., 1986) . In our experiments the effect of 4,B-PDB on evoked acetylcholine release was tested at various Ca2"-concentrations from 0.65 mM to 5.2 mM ( Figure  3 ). When Ca2" was used below 0.65 mM, the stimulated release was almost abolished. The net increase caused by the phorbol ester was reduced at lower Ca2"-concentrations (Figure 3) . No clear and significant correlation was seen between extracellular Ca2"-levels and the relative facilitatory effect of the phorbol ester.
Polymyxin B has been used by several groups investigating the mechanism of release of noradrenaline, 5-hydroxytryptamine and acetylcholine as a putative inhibitor of protein kinase C Wakade et al., 1986; Tanaka et al., 1986; Feuerstein et al., 1987; Versteeg & Ulenkate, 1987) . In each of these studies polymyxin B diminished the stimulated release and counteracted the enhancement of release caused by the phorbol esters. Since the relative inhibitory effect of polymyxin B remained unchanged a functional antagonism and not a competitive one was assumed (Feuerstein et al., 1987; Versteeg & Ulenkate, 1987) . The same conclusion can be drawn from the present data in regard to acetylcholine release. However, the mechanism by which polymyxin B antagonizes the phorbol ester-induced facilitation of transmitter release requires further investigation.
In contrast to the action of polymyxin B the net effect of inhibition, i.e. the absolute reduction of tritium overflow caused by the muscarine receptor agonists, oxotremorine and carbachol, was not changed in the presence of 4P-PDB (Table 5 ). In addition, transmitter release was increased by 4P-PDB and atropine in an additive manner, both under conditions of weak or strong (when acetylcholine esterase was inhibited) autoinhibition ( Figure 2 ). Each drug was used at or near to a concentration that caused maximum facilitation of release. Both the unchanged inhibitory net effects of the muscarine receptor agonists as well as the additive nature of the effects of 4p-PDB and atropine exclude the possibility that the enhancement of release was due to an inactivation of the autoreceptor-coupled inhibitory feedback system by the phorbol ester. In addition, a direct participation of protein kinase C in the post muscarine receptor mechanism seems to be very unlikely. Similar interpretation of experimental data concerning autoreceptor-mediated modulation of acetylcholine release in rat hippocampus was given by Versteeg & Florijn (1987) Versteeg & Florijn 1987 ) and [3H]-5-hydroxytryptamine (Feuerstein et al., 1987) release from hippocampal slices were studied.
Inhibition of acetylcholine release by the heteroreceptor agonists (-)-PIA (Table 7) and EKC (Table 8) also appears not to be directly affected by protein kinase C activation, since similar inhibitory effects of both agonists were seen, irrespective of whether the phorbol ester was present or absent. From these and former results Feuerstein et al., 1987; Versteeg & Florijn, 1987) it can be assumed that, while protein kinase C generally participates in the modulation of the evoked transmitter release, this enzyme is not directly linked to mechanisms mediating inhibition of release via presnyaptic receptors.
